| Product Code: ETC9970791 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Monkeypox Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Monkeypox Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Monkeypox Market - Industry Life Cycle |
3.4 United States (US) Monkeypox Market - Porter's Five Forces |
3.5 United States (US) Monkeypox Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 United States (US) Monkeypox Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.7 United States (US) Monkeypox Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Monkeypox Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of monkeypox cases in the United States |
4.2.2 Growing awareness about monkeypox and its transmission |
4.2.3 Investments in research and development for monkeypox treatments and vaccines |
4.3 Market Restraints |
4.3.1 Regulatory hurdles in the approval of monkeypox treatments and vaccines |
4.3.2 Limited availability of effective treatment options for monkeypox |
4.3.3 Public hesitancy towards monkeypox vaccination programs |
5 United States (US) Monkeypox Market Trends |
6 United States (US) Monkeypox Market, By Types |
6.1 United States (US) Monkeypox Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Monkeypox Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 United States (US) Monkeypox Market Revenues & Volume, By Cidofovir, 2021- 2031F |
6.1.4 United States (US) Monkeypox Market Revenues & Volume, By Brincidofovir, 2021- 2031F |
6.1.5 United States (US) Monkeypox Market Revenues & Volume, By Tecovirimat, 2021- 2031F |
6.1.6 United States (US) Monkeypox Market Revenues & Volume, By Vaccinia ImmuneGlobulin, 2021- 2031F |
6.2 United States (US) Monkeypox Market, By End users |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Monkeypox Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.3 United States (US) Monkeypox Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.4 United States (US) Monkeypox Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Monkeypox Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Monkeypox Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.3.3 United States (US) Monkeypox Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.4 United States (US) Monkeypox Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.5 United States (US) Monkeypox Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.6 United States (US) Monkeypox Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Monkeypox Market Import-Export Trade Statistics |
7.1 United States (US) Monkeypox Market Export to Major Countries |
7.2 United States (US) Monkeypox Market Imports from Major Countries |
8 United States (US) Monkeypox Market Key Performance Indicators |
8.1 Number of reported monkeypox cases in the United States |
8.2 Funding allocation towards monkeypox research and development |
8.3 Adoption rate of monkeypox prevention and control measures by healthcare facilities |
9 United States (US) Monkeypox Market - Opportunity Assessment |
9.1 United States (US) Monkeypox Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 United States (US) Monkeypox Market Opportunity Assessment, By End users, 2021 & 2031F |
9.3 United States (US) Monkeypox Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Monkeypox Market - Competitive Landscape |
10.1 United States (US) Monkeypox Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Monkeypox Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here